Слотвицкий Михаил Михайлович

1) Фиброзы и их моделирование, моделирование постинфарктных рубцов.
2) Клеточная регенеративная медицина.
3) Системы сохранения донорского сердца и неинвазивной оценки функциональности.
4) Кардиотоксичность и системы подбора лекарственных средств

1. Slotvitsky M. M. et al. formation of an electrical coupling between differentiating cardiomyocytes //Scientific reports. – 2020. – Т. 10. – №. 1. – С. 1-11.
https://www.nature.com/articles/s41598-020-64581-5
https://doi.org/10.1038/s41598-020-64581-5
Impact factor: 3.998 (2019), (Q1)

2. Slotvitsky M. et al. Arrhythmogenicity test based on a human-induced pluripotent stem cell (iPSC)-derived cardiomyocyte layer //Toxicological Sciences. – 2018. – Т. 168. – №. 1. – С. 70-77.
https://academic.oup.com/toxsci/article-abstract/168/1/70/5156075
doi: 10.1093/toxsci/kfy274
5 Year Impact Factor 4.132, (Q1)

3. Podgurskaya A. D. et al. Cyclophosphamide arrhythmogenicitytesting using human-induced pluripotent stem cell-derived cardiomyocytes //Scientific reports. – 2021. – Т. 11. – №. 1. – С. 1-13.
https://www.nature.com/articles/s41598-020-79085-5
Impact factor: 3.998 (2019), (Q1)

4. Podgurskaya A. D. et al. The Use of iPSC-Derived Cardiomyocytes and Optical Mapping for Erythromycin Arrhythmogenicity Testing //Cardiovascular toxicology. – 2019. – С. 1-11.
https://link.springer.com/article/10.1007/s12012-019-09532-x
https://doi.org/10.1007/s12012-019-09532-x
Impact factor: 2.630 (2018), (Q2)

5. Dementyeva E. V. et al. Applying Patient-Specific Induced Pluripotent Stem Cells to Create a Model of Hypertrophic Cardiomyopathy //Biochemistry (Moscow). – 2019. – Т. 84. – №. 3. – С. 291-298.